The Brenner laboratory is thrilled to announce our move to University of Helsinki on 1 July 2026. Read the latest press release “Introducing Dr. Charles Brenner – Forever curious and passionate for uncharted research questions“
We’re bringing our passion for solving unsolved problems in NAD metabolism, using Citrin Deficiency as a powerful model of MASLD, decoding the logic of ChREBP function, and characterizing new dimensions of nicotine toxicity.
The lab is expanding. Please read our publications carefully and be in touch!